Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn Guenther

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Cutaneous Medicine and Surgery|March 16, 2012
Pathway to dry skin prevention and treatmentLyn Guenther, Chuck W Lynde, Anneke Andriessen, et al.
Dermatology and Therapy|March 28, 2024
Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic DermatitisLawrence F Eichenfield, Linda F Stein Gold, Charles Lynde, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2017
The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital PsoriasisJoseph F Merola, Alison Potts Bleakman, Alice B Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 10, 2025
Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasisJoseph F Merola, Lyn Guenther, Charles Lynde, et al.
Dermatology and Therapy|October 28, 2017
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative StudyJennifer Clay Cather, Caitriona Ryan, Kim Meeuwis, et al.
Journal of Cutaneous Medicine and Surgery|March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi StudyChristine Fahim, Ben Whan Kim, Marc Bourcier, et al.
Journal of the American Academy of Dermatology|October 18, 2023
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trialJoseph F Merola, Lawrence Charles Parish, Lyn Guenther, et al.
Journal of Drugs in Dermatology : JDD|October 3, 2013
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab useCarrie Brodmerkel, Eric Wadman, Richard G Langley, et al.
The Journal of Dermatological Treatment|August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysisKim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasisKim A Papp, Lyn Guenther, Bernard Boyden, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Cutaneous Medicine and Surgery|March 16, 2012
Pathway to dry skin prevention and treatmentLyn Guenther, Chuck W Lynde, Anneke Andriessen, et al.
Dermatology and Therapy|March 28, 2024
Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic DermatitisLawrence F Eichenfield, Linda F Stein Gold, Charles Lynde, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2017
The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital PsoriasisJoseph F Merola, Alison Potts Bleakman, Alice B Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 10, 2025
Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasisJoseph F Merola, Lyn Guenther, Charles Lynde, et al.
Dermatology and Therapy|October 28, 2017
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative StudyJennifer Clay Cather, Caitriona Ryan, Kim Meeuwis, et al.
Journal of Cutaneous Medicine and Surgery|March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi StudyChristine Fahim, Ben Whan Kim, Marc Bourcier, et al.
Journal of the American Academy of Dermatology|October 18, 2023
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trialJoseph F Merola, Lawrence Charles Parish, Lyn Guenther, et al.
Journal of Drugs in Dermatology : JDD|October 3, 2013
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab useCarrie Brodmerkel, Eric Wadman, Richard G Langley, et al.
The Journal of Dermatological Treatment|August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysisKim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasisKim A Papp, Lyn Guenther, Bernard Boyden, et al.
Pageof 6